Zacks Research Has Negative Outlook for MOH Q3 Earnings

Key Points

• Zacks Research has reduced its earnings per share estimate for Molina Healthcare's Q3 2025 from $5.71 to $4.23, indicating a significant decline in expected profitability.
• Molina Healthcare reported a Q2 earnings miss with $5.48 per share compared to a consensus estimate of $5.50, despite a revenue increase of 15.7% year-over-year to $11.43 billion.
• Several investment firms, including Cantor Fitzgerald and JPMorgan Chase & Co., have downgraded their ratings and lowered price targets for Molina Healthcare, contributing to a consensus "Hold" rating among analysts.

Molina Healthcare, Inc (NYSE:MOH - Free Report) - Equities research analysts at Zacks Research decreased their Q3 2025 earnings per share (EPS) estimates for shares of Molina Healthcare in a note issued to investors on Wednesday, August 13th. Zacks Research analyst Team now anticipates that the company will post earnings per share of $4.23 for the quarter, down from their previous forecast of $5.71. The consensus estimate for Molina Healthcare's current full-year earnings is $24.40 per share. Zacks Research also issued estimates for Molina Healthcare's Q4 2025 earnings at $3.25 EPS, FY2025 earnings at $19.04 EPS, Q1 2026 earnings at $5.83 EPS, Q2 2026 earnings at $5.34 EPS, Q3 2026 earnings at $4.55 EPS, Q4 2026 earnings at $5.52 EPS, FY2026 earnings at $21.24 EPS, Q1 2027 earnings at $11.18 EPS, Q2 2027 earnings at $6.23 EPS and FY2027 earnings at $25.40 EPS.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.50 by ($0.02). The company had revenue of $11.43 billion for the quarter, compared to the consensus estimate of $10.94 billion. Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%.The firm's revenue for the quarter was up 15.7% on a year-over-year basis. During the same period in the prior year, the business earned $5.86 earnings per share.

MOH has been the subject of a number of other reports. Morgan Stanley downgraded Molina Healthcare from an "overweight" rating to an "equal weight" rating and decreased their price target for the stock from $364.00 to $266.00 in a report on Thursday, July 10th. Robert W. Baird decreased their price target on Molina Healthcare from $373.00 to $179.00 and set a "neutral" rating for the company in a report on Friday, July 25th. JPMorgan Chase & Co. decreased their price target on Molina Healthcare from $272.00 to $184.00 and set a "neutral" rating for the company in a report on Tuesday, July 29th. Sanford C. Bernstein started coverage on Molina Healthcare in a report on Tuesday, April 22nd. They set an "outperform" rating and a $414.00 price target for the company. Finally, Mizuho decreased their price target on Molina Healthcare from $400.00 to $330.00 and set an "outperform" rating for the company in a report on Friday, July 11th. Three research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat, Molina Healthcare has a consensus rating of "Hold" and a consensus target price of $242.91.

Molina Healthcare Trading Up 2.7%

NYSE:MOH traded up $4.49 during trading hours on Friday, hitting $173.64. 1,753,146 shares of the company were exchanged, compared to its average volume of 983,906. The stock has a market capitalization of $9.41 billion, a price-to-earnings ratio of 8.56 and a beta of 0.52. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.77. Molina Healthcare has a one year low of $151.95 and a one year high of $365.23. The company has a fifty day simple moving average of $220.74 and a 200 day simple moving average of $280.58.

Insider Activity

In related news, Director Ronna Romney sold 700 shares of the firm's stock in a transaction dated Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total value of $107,618.00. Following the transaction, the director owned 17,131 shares of the company's stock, valued at approximately $2,633,719.94. This trade represents a 3.93% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO James Woys purchased 10,000 shares of the company's stock in a transaction that occurred on Monday, August 4th. The stock was acquired at an average cost of $155.94 per share, for a total transaction of $1,559,400.00. Following the transaction, the chief operating officer owned 74,331 shares in the company, valued at $11,591,176.14. This represents a 15.54% increase in their position. The disclosure for this purchase can be found here. 1.26% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Molina Healthcare

Several large investors have recently added to or reduced their stakes in the business. Rothschild Investment LLC lifted its position in shares of Molina Healthcare by 126.3% during the 1st quarter. Rothschild Investment LLC now owns 86 shares of the company's stock worth $28,000 after buying an additional 48 shares in the last quarter. Zions Bancorporation National Association UT bought a new position in shares of Molina Healthcare during the 1st quarter worth approximately $29,000. Deseret Mutual Benefit Administrators lifted its position in shares of Molina Healthcare by 60.7% during the 1st quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock worth $30,000 after buying an additional 34 shares in the last quarter. Elequin Capital LP lifted its position in shares of Molina Healthcare by 170.6% during the 1st quarter. Elequin Capital LP now owns 92 shares of the company's stock worth $30,000 after buying an additional 58 shares in the last quarter. Finally, Colonial Trust Co SC lifted its position in shares of Molina Healthcare by 930.0% during the 4th quarter. Colonial Trust Co SC now owns 103 shares of the company's stock worth $30,000 after buying an additional 93 shares in the last quarter. Institutional investors own 98.50% of the company's stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.